HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veikko Salomaa Selected Research

migen

1/2012Hypothesis-based analysis of gene-gene interactions and risk of myocardial infarction.
3/2011Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veikko Salomaa Research Topics

Disease

57Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 01/2002
33Coronary Disease (Coronary Heart Disease)
09/2022 - 02/2002
32Obesity
01/2022 - 12/2003
29Type 2 Diabetes Mellitus (MODY)
01/2022 - 02/2008
26Inflammation (Inflammations)
01/2022 - 10/2002
22Stroke (Strokes)
04/2022 - 08/2002
19Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 02/2008
18Heart Failure
05/2022 - 01/2013
17Myocardial Infarction
04/2022 - 05/2008
15Insulin Resistance
12/2019 - 02/2006
14Hypertension (High Blood Pressure)
01/2022 - 03/2009
13Atherosclerosis
01/2019 - 12/2002
10Atrial Fibrillation
01/2021 - 01/2012
10Ischemic Stroke
12/2020 - 03/2005
10Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2019 - 03/2007
9Neoplasms (Cancer)
11/2022 - 02/2011
9Liver Diseases (Liver Disease)
01/2022 - 05/2015
7Acute Coronary Syndrome
12/2021 - 09/2005
6Dyslipidemias (Dyslipidemia)
01/2022 - 02/2006
6Genetic Risk Score
01/2021 - 11/2016
6Diabetes Mellitus
12/2020 - 06/2012
5Dementia (Dementias)
01/2018 - 01/2015
5Tobacco Use Disorder (Nicotine Dependence)
01/2016 - 05/2010
4Hemorrhage
05/2022 - 10/2014
4Glucose Intolerance
01/2021 - 06/2012
4Gout
10/2018 - 06/2009
4Alzheimer Disease (Alzheimer's Disease)
01/2018 - 12/2016
3Lung Neoplasms (Lung Cancer)
11/2022 - 12/2013
3Chronic Renal Insufficiency
01/2022 - 10/2015
3Heart Diseases (Heart Disease)
12/2021 - 08/2012
3Endotoxemia
11/2021 - 02/2011
3Fibrosis (Cirrhosis)
06/2021 - 03/2011
3Infections
08/2020 - 04/2015
3Hypercholesterolemia
01/2020 - 04/2006
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2020 - 01/2015
3Periodontitis
12/2019 - 07/2003
3Metabolic Diseases (Metabolic Disease)
12/2019 - 08/2014
3Asthma (Bronchial Asthma)
10/2018 - 10/2002
3Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 01/2016
3Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
01/2016 - 08/2009
3Heart Valve Diseases (Valvular Heart Disease)
08/2015 - 02/2013
2Mental Disorders (Mental Disorder)
05/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

47LipidsIBA
01/2022 - 02/2010
38CholesterolIBA
04/2022 - 12/2005
37Biomarkers (Surrogate Marker)IBA
11/2022 - 06/2010
21HDL CholesterolIBA
01/2022 - 02/2008
19C-Reactive ProteinIBA
04/2022 - 10/2002
17Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2006
15Triglycerides (Triacylglycerol)IBA
04/2022 - 02/2008
15LDL CholesterolIBA
01/2022 - 02/2008
15Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2010
14Lipoproteins (Lipoprotein)IBA
12/2021 - 09/2002
12Insulin (Novolin)FDA Link
04/2022 - 12/2002
12oxidized low density lipoproteinIBA
01/2022 - 02/2008
12pro-brain natriuretic peptide (1-76)IBA
11/2021 - 05/2014
11HDL LipoproteinsIBA
01/2022 - 09/2002
11Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021 - 10/2011
9CytokinesIBA
11/2022 - 05/2009
9Pharmaceutical PreparationsIBA
05/2022 - 06/2007
9Biological ProductsIBA
12/2021 - 09/2010
8Troponin IIBA
01/2021 - 09/2005
7TroponinIBA
01/2020 - 09/2005
6EnzymesIBA
01/2022 - 12/2002
6Glycoproteins (Glycoprotein)IBA
01/2021 - 12/2014
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2018 - 01/2006
5omega-Chloroacetophenone (Mace)IBA
04/2022 - 01/2014
5Natriuretic PeptidesIBA
11/2021 - 03/2009
5ApolipoproteinsIBA
06/2021 - 02/2006
5Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 04/2015
5Amino AcidsFDA Link
12/2020 - 08/2014
5AdiponectinIBA
09/2019 - 06/2011
4Antihypertensive Agents (Antihypertensives)IBA
04/2022 - 04/2006
4Vitamin DFDA LinkGeneric
03/2021 - 01/2013
4Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2020 - 05/2011
4LDL Lipoproteins (beta Lipoproteins)IBA
12/2019 - 02/2008
4Lipoprotein(a)IBA
01/2018 - 03/2005
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2016 - 05/2010
4Fibrinogen (Factor I)FDA Link
10/2012 - 10/2002
3Interleukin-18 (Interleukin 18)IBA
11/2022 - 12/2008
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
11/2022 - 10/2010
3VLDL LipoproteinsIBA
04/2022 - 01/2018
3CreatinineIBA
01/2022 - 01/2018
3LipopolysaccharidesIBA
11/2021 - 04/2015
3Testosterone (Sustanon)FDA Link
01/2021 - 01/2018
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2019 - 12/2014
3ORALIT (ORS)IBA
12/2019 - 04/2015
3EndotoxinsIBA
11/2019 - 06/2007
3InterleukinsIBA
01/2017 - 09/2008
3Hormones (Hormone)IBA
12/2016 - 01/2012
3Apolipoproteins B (ApoB)IBA
12/2016 - 05/2011
3Messenger RNA (mRNA)IBA
01/2016 - 02/2006
3Hemoglobins (Hemoglobin)IBA
01/2016 - 12/2013
3Uric Acid (Urate)IBA
01/2015 - 06/2009
3AntibodiesIBA
12/2013 - 07/2003
3Hemostatics (Antihemorrhagics)IBA
07/2005 - 02/2002
2Isoleucine (L-Isoleucine)FDA Link
04/2022 - 01/2018

Therapy/Procedure

8Therapeutics
08/2020 - 03/2016
3Secondary Prevention
03/2016 - 12/2005
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2022 - 08/2002
2Percutaneous Coronary Intervention
09/2022 - 12/2013